|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Graceway Pharmaceuticals, LLC |
|---|---|
| Information provided by: | Graceway Pharmaceuticals, LLC |
| ClinicalTrials.gov Identifier: | NCT00116675 |
Purpose
The primary purpose of this study is to evaluate the effectiveness in pediatric subjects of three different strengths of resiquimod gel applied to common wart(s) three times a week for four weeks.
A second purpose is to evaluate the safety of the drug.
| Condition | Intervention | Phase |
|---|---|---|
|
Warts |
Drug: Resiquimod |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Single Blind, Dose Comparison, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for 4 Weeks for the Treatment of Common Warts in Pediatric Subjects |
Eligibility| Ages Eligible for Study: | 3 Years to 11 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Arkansas | |
| Children's Clinic of Jonesboro, PA | |
| Jonesboro, Arkansas, United States, 72401 | |
| United States, California | |
| University of California - San Francisco | |
| San Francisco, California, United States, 94143 | |
| United States, Colorado | |
| Longmont Clinic/Longmont Medical Research Network | |
| Longmont, Colorado, United States, 80501 | |
| United States, Missouri | |
| Mercy Health Research | |
| St. Louis, Missouri, United States, 63141 | |
| United States, New Hampshire | |
| Dartmouth-Hitchcock Medical Center | |
| Lebanon, New Hampshire, United States, 03756 | |
| United States, Rhode Island | |
| Rhode Island Hospital - Jane Brown Building | |
| Providence, Rhode Island, United States, 02903 | |
| United States, Texas | |
| DermResearch, Inc. | |
| Austin, Texas, United States, 78759 | |
| United States, Utah | |
| Alpine Pediatrics | |
| Pleasant Grove, Utah, United States, 84062 | |
| United States, Washington | |
| Walla Walla Clinic | |
| Walla Walla, Washington, United States, 99362 | |
| United States, Wisconsin | |
| Advanced Healthcare | |
| Milwaukee, Wisconsin, United States, 53209 | |
More Information
| Study ID Numbers: | 1535-RESI |
| Study First Received: | June 30, 2005 |
| Last Updated: | February 16, 2007 |
| ClinicalTrials.gov Identifier: | NCT00116675 |
| Health Authority: | United States: Food and Drug Administration |
|
Common Wart(s) Pediatric Wart(s) |
Children 3M Pharmaceuticals Resiquimod |
|
Virus Diseases Skin Diseases, Infectious Warts |
Skin Diseases DNA Virus Infections Papillomavirus Infections |
|
Skin Diseases, Viral Neoplasms Tumor Virus Infections |
